Target Identification of Kinase Inhibitor Alisertib (MLN8237) by Using DNA-Programmed Affinity Labeling.
暂无分享,去创建一个
Yan Cao | Xiaoyu Li | Z. Hong | Y. Chai | Zhenyu Zhu | Xiaofei Chen | Dong-Yao Wang | Le-Yi Zheng | Lang-Dong Chen | Xiao-Fei Chen | Zhan-Ying Hong | Zhen-Yu Zhu | Xiaoyu Li | Yi-Feng Chai | Yan Cao | Langdong Chen | Dongyao Wang | Leyi Zheng | Z. Zhu
[1] Mindy I. Davis,et al. Comprehensive analysis of kinase inhibitor selectivity , 2011, Nature Biotechnology.
[2] S. Sze,et al. Design and synthesis of minimalist terminal alkyne-containing diazirine photo-crosslinkers and their incorporation into kinase inhibitors for cell- and tissue-based proteome profiling. , 2013, Angewandte Chemie.
[3] G. Schwartz,et al. Phase II study of MLN8237 (Alisertib) in advanced/metastatic sarcoma. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[4] Shipra Agrawal,et al. Biology of Aurora A kinase: Implications in cancer manifestation and therapy , 2011, Medicinal research reviews.
[5] W. Earnshaw,et al. Making the Auroras glow: regulation of Aurora A and B kinase function by interacting proteins , 2009, Current opinion in cell biology.
[6] B. Cravatt,et al. Mapping the Protein Interaction Landscape for Fully Functionalized Small-Molecule Probes in Human Cells , 2014, Journal of the American Chemical Society.
[7] A. Lavecchia,et al. Discovery of new small molecules inhibiting 67 kDa laminin receptor interaction with laminin and cancer cell invasion , 2015, Oncotarget.
[8] W. Y. Man,et al. Tetraploidization increases sensitivity to Aurora B kinase inhibition , 2012, Cell cycle.
[9] A. Cuadrado,et al. Mechanisms and functions of p38 MAPK signalling. , 2010, The Biochemical journal.
[10] S. Pinel,et al. Les inhibiteurs des kinases Aurora , 2009 .
[11] M. Malumbres,et al. Aurora kinase A inhibitors: promising agents in antitumoral therapy , 2014, Expert opinion on therapeutic targets.
[12] S. Yao,et al. "Minimalist" cyclopropene-containing photo-cross-linkers suitable for live-cell imaging and affinity-based protein labeling. , 2014, Journal of the American Chemical Society.
[13] R. Timpl,et al. Protease resistance and conformation of laminin. , 1982, European journal of biochemistry.
[14] J. Das. Aliphatic diazirines as photoaffinity probes for proteins: recent developments. , 2011, Chemical reviews.
[15] T. Hosoya,et al. 3-Azidodifluoromethyl-3H-diazirin-3-yl group as an all-in-one functional group for radioisotope-free photoaffinity labeling. , 2007, Organic & biomolecular chemistry.
[16] L. Liotta,et al. Role of laminin receptor in tumor cell migration. , 1987, Cancer research.
[17] H. Cha,et al. Depletion of Aurora A leads to upregulation of FoxO1 to induce cell cycle arrest in hepatocellular carcinoma cells , 2013, Cell cycle.
[18] S. Ménard,et al. Co-regulation and Physical Association of the 67-kDa Monomeric Laminin Receptor and the α6β4 Integrin* , 1997, The Journal of Biological Chemistry.
[19] D. Grimm,et al. The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors , 2017, International journal of molecular sciences.
[20] Qing Yang,et al. Prognostic value of Aurora kinase A (AURKA) expression among solid tumor patients: a systematic review and meta-analysis. , 2015, Japanese journal of clinical oncology.
[21] P. Clemons,et al. Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.
[22] K. Henkels,et al. A non-mitotic role for Aurora kinase A as a direct activator of cell migration upon interaction with PLD, FAK and Src , 2015, Journal of Cell Science.
[23] Gang Li,et al. Affinity purification in target identification: the specificity challenge , 2015, Archives of Pharmacal Research.
[24] M. Bogyo,et al. Target deconvolution techniques in modern phenotypic profiling. , 2013, Current opinion in chemical biology.
[25] B. Leslie,et al. Identification of the cellular targets of bioactive small organic molecules using affinity reagents. , 2008, Chemical Society reviews.
[26] H. Waldmann,et al. Identifizierung der Zielproteine bioaktiver Verbindungen: Die Suche nach der Nadel im Heuhaufen , 2013 .
[27] Rachel E. Gershman,et al. Characterization of Alisertib (MLN8237), an Investigational Small-Molecule Inhibitor of Aurora A Kinase Using Novel In Vivo Pharmacodynamic Assays , 2011, Clinical Cancer Research.
[28] Y. Liu,et al. Photoaffinity labeling of transcription factors by DNA-templated crosslinking , 2014, Chemical science.
[29] Jiahuai Han,et al. Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.
[30] D. Zheleva,et al. Aurora kinases: structure, functions and their association with cancer. , 2008, Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia.
[31] Ming-Wei Wang,et al. Application of chemical biology in target identification and drug discovery , 2015, Archives of Pharmacal Research.
[32] Clive S Mason,et al. Drug-resistant aurora A mutants for cellular target validation of the small molecule kinase inhibitors MLN8054 and MLN8237. , 2010, ACS chemical biology.
[33] Shin-ichi Sato,et al. Biochemical target isolation for novices: affinity-based strategies. , 2010, Chemistry & biology.
[34] S. Koul,et al. Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.
[35] R. Weissleder,et al. Bioorthogonal imaging of aurora kinase A in live cells. , 2012, Angewandte Chemie.
[36] Andrew Emili,et al. Proteomic methods for drug target discovery. , 2008, Current opinion in chemical biology.
[37] S. Ménard,et al. Peptide G, Containing the Binding Site of the 67-kDa Laminin Receptor, Increases and Stabilizes Laminin Binding to Cancer Cells* , 1996, The Journal of Biological Chemistry.
[38] Qing Jiang,et al. Roles of Aurora Kinases in Mitosis and Tumorigenesis , 2007, Molecular Cancer Research.
[39] J. Blenis,et al. ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions , 2004, Microbiology and Molecular Biology Reviews.
[40] S. Knapp,et al. Exploration of Type II Binding Mode: A Privileged Approach for Kinase Inhibitor Focused Drug Discovery? , 2014, ACS chemical biology.
[41] Y. Liu,et al. Photoaffinity labeling of small-molecule-binding proteins by DNA-templated chemistry. , 2013, Angewandte Chemie.
[42] Ken Jacobson,et al. MAP kinases and cell migration , 2004, Journal of Cell Science.
[43] Wade H. Dunham,et al. Affinity‐purification coupled to mass spectrometry: Basic principles and strategies , 2012, Proteomics.
[44] C. Hofmeister,et al. A Phase Ib Study of the combination of the Aurora Kinase Inhibitor Alisertib (MLN8237) and Bortezomib in Relapsed Multiple Myeloma , 2016, British journal of haematology.
[45] F. Gao,et al. Advance in the study on p38 MAPK mediated drug resistance in leukemia. , 2016, European review for medical and pharmacological sciences.
[46] Stephen S. Taylor,et al. Aurora-kinase inhibitors as anticancer agents , 2004, Nature Reviews Cancer.
[47] Radha Akella,et al. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. , 2002, Molecular cell.
[48] J. Pollard,et al. Discovery and development of aurora kinase inhibitors as anticancer agents. , 2009, Journal of medicinal chemistry.
[49] S. Sze,et al. Multiplex Imaging and Cellular Target Identification of Kinase Inhibitors via an Affinity-Based Proteome Profiling Approach , 2015, Scientific Reports.
[50] Hongming Pan,et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. , 2014, Cancer letters.
[51] E. Wagner,et al. Signal integration by JNK and p38 MAPK pathways in cancer development , 2009, Nature Reviews Cancer.
[52] V. Castronovo,et al. Functional domains of the 67-kDa laminin receptor precursor. , 1991, The Journal of biological chemistry.
[53] H. Osada,et al. Affinity-based target identification for bioactive small molecules , 2014 .
[54] A. Cervantes,et al. Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[55] W. Earnshaw,et al. The cellular geography of Aurora kinases , 2003, Nature Reviews Molecular Cell Biology.
[56] E. Gallop‐Evans. The role of alisertib in treatment of peripheral T-cell lymphomas. , 2015, Future oncology.
[57] D. Meruelo,et al. Looking into laminin receptor: critical discussion regarding the non‐integrin 37/67‐kDa laminin receptor/RPSA protein , 2016, Biological reviews of the Cambridge Philosophical Society.
[58] S. Yao,et al. Target identification of natural products and bioactive compounds using affinity-based probes. , 2016, Natural product reports.
[59] Philippe P Roux,et al. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases , 2011, Microbiology and Molecular Reviews.
[60] Herbert Waldmann,et al. Target identification for small bioactive molecules: finding the needle in the haystack. , 2013, Angewandte Chemie.
[61] Kaori Sasai,et al. Functional significance of Aurora kinase A in centrosome amplification and genomic instability. , 2008, Advances in experimental medicine and biology.
[62] S. Linardopoulos,et al. Aurora Kinase Inhibitors: Current Status and Outlook , 2015, Front. Oncol..
[63] N. Kanoh. Photo-cross-linked small-molecule affinity matrix as a tool for target identification of bioactive small molecules. , 2016, Natural product reports.
[64] J. Crispino,et al. The Aurora Kinases in Cell Cycle and Leukemia , 2014, Oncogene.
[65] Shufeng Zhou,et al. A SILAC-based proteomics elicits the molecular interactome of alisertib (MLN8237) in human erythroleukemia K562 cells. , 2015, American journal of translational research.
[66] R. Young,et al. Design and synthesis of an all-in-one 3-(1,1-difluoroprop-2-ynyl)-3H-diazirin-3-yl functional group for photo-affinity labeling. , 2009, Bioorganic & medicinal chemistry.
[67] M. Wright,et al. Chemical proteomics approaches for identifying the cellular targets of natural products , 2016, Natural product reports.
[68] K. Sakurai. Photoaffinity Probes for Identification of Carbohydrate‐Binding Proteins , 2015 .
[69] J. Friedberg,et al. T‐Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment , 2017, Journal of the National Cancer Institute.
[70] Hiroshi Aoyama,et al. Design of dantrolene-derived probes for radioisotope-free photoaffinity labeling of proteins involved in the physiological Ca2+ release from sarcoplasmic reticulum of skeletal muscle. , 2005, Bioorganic & medicinal chemistry letters.
[71] Jos H Beijnen,et al. Clinical experience with aurora kinase inhibitors: a review. , 2009, The oncologist.
[72] M. Endo,et al. Novel bifunctional probe for radioisotope-free photoaffinity labeling: compact structure comprised of photospecific ligand ligation and detectable tag anchoring units. , 2004, Organic & biomolecular chemistry.
[73] A. Godwin,et al. Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion , 2014, Oncogene.
[74] Jongmin Park,et al. From noncovalent to covalent bonds: a paradigm shift in target protein identification. , 2013, Molecular bioSystems.
[75] S. Yao,et al. Fluorescent Probes for Single-Step Detection and Proteomic Profiling of Histone Deacetylases. , 2016, Journal of the American Chemical Society.
[76] M. Sobel,et al. The 67-kDa laminin receptor and tumor progression. , 1996, Current topics in microbiology and immunology.
[77] Yuguo Zheng,et al. Target identification of biologically active small molecules via in situ methods. , 2013, Current opinion in chemical biology.
[78] F. Gergely,et al. Aurora-A: the maker and breaker of spindle poles , 2007, Journal of Cell Science.
[79] B. Cravatt,et al. Fully functionalized small-molecule probes for integrated phenotypic screening and target identification. , 2012, Journal of the American Chemical Society.
[80] Gang Li,et al. Multivalent photoaffinity probe for labeling small molecule binding proteins. , 2014, Bioconjugate chemistry.